Ann: Kazia paxilisib in Dana Farber study enrols first patient, page-36

“How can I spell it out better - needle with the authority inside the company, with input into better disclosure on GBM application timing....... you would have it by mid morning tomorrow.”

—-

Does Needle now refer to Needle in the third person!? Are you seriously suggesting you should be nominated to the board???

Look … You are most welcome to your delusions but please don’t get in the way of the Kazia team working in and on our business and advancing our compounds…

they are dealing with important and full work loads on Paxalisib and EVT801 plus all the lic deals.

we have a very capable and experienced team hopefully they will be focused and left to their good works without frivolous distractions